Delivery Order SPE2DB24D2205-SPE2DB25FEDBR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,506.66 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,015.34 to AmerisourceBergen Drug Corp for the supply of Depakote ER 250 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on June 6, 2025, is scheduled for completion by June 9, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order valued at $3,092.44 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,549.92, is for the delivery of DEPAKOTE DR 500 MG TABLET 100S, a neurological medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $1,921.72. The award was made on July 30, 2025, with a completion date of July 31, 2025, under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEPAKOTE DR 500 MG TABLET 100S. The contract has a ceiling value of $3,376.57 and a completion date of January 14, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Depakote DR 125 mg sprinkle capsules (100 count) with a ceiling value of $3,165.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is scheduled for ultimate completion on September 5, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count unit) valued at $1,458.55. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $3,014.25 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single shipment of this anticonvulsant and mood-stabilizing medication,...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.84 to AmerisourceBergen Drug Corp for 100 sprinkle capsules of Depakote DR 125 mg, an anticonvulsant and mood-stabilizing medication commonly used in military and veteran healthcare systems. This non-set-aside contract reflects a firm fixed price arrangement with a place of performance in Conshohocken, Pennsylvania, and was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The delivery order...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDBRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,660.44 to AmerisourceBergen Drug Corp for DEPAKOTE ER 500 mg tablets (100-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract utilizes firm fixed pricing and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. DEPAKOTE ER, an antiepileptic and mood-stabilizing medication, represents one component of the extensive pharmaceutical portfolio that AmerisourceBergen delivers through its DLA contract, which encompasses specialty medications, vaccines, and medical supplies across multiple therapeutic domains. The contract supports critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/2/25 |